Abramson Cancer Center At Penn Medicine

This study tests whether injecting a new treatment called RP2 directly into stomach or esophageal tumors, along with standard chemotherapy (FLOT), is safe and works better than chemo alone before surgery. About 34 people with stage 2 or higher non-metastatic cancer will take part…

This study tests whether giving focused radiation or surgery to all remaining cancer spots can allow kidney cancer patients to stop their regular treatment for at least a year. It involves 23 adults with metastatic clear cell kidney cancer who have already had stable or improved …

This early-stage trial tests whether giving radiation therapy and the antibiotic vancomycin before standard CAR-T cell treatment is safe and doable for people with large B-cell lymphoma. About 14 adults whose lymphoma has come back or not responded to treatment will take part. Th…

This study will check how well a new blood test, called SpotitEarly, can detect breast cancer in women. About 500 women will take part, including those at higher risk due to age, genetics, or family history. The goal is to see if the test is accurate and works well for different …

This study tests a mobile health tool to help women on hormone therapy for breast cancer understand and manage side effects. Researchers will enroll 60 women to see if the app is easy to use and helps them stay on their medication. The goal is to improve quality of life and treat…